Loading company…
SpePharm develops and commercializes pharmaceutical products, including treatments in gastroenterology and hepatology.
SpePharm is a pharmaceutical company based in Amsterdam, Netherlands, focused on developing and commercializing therapeutic products. Its activities include products in gastroenterology and hepatology, as well as licensing and acquisition partnerships. In March 2014, Clinigen Group acquired its oncology support therapy division, Savene. SpePharm raised EUR 7.000 mn from investors including Signet Healthcare Partners, TVM Capital Life Science, and Top Tier Capital Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in